RxDoctor Payments Data

Piyush Aggarwal, MD

Colon & Rectal Surgery · Walnut Creek, CANPI 1700070273

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (30.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 63.4% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $4,006 and has fallen 99.2% since, to $33 in 2025.

$8,893in general payments, 2019–2025

Across 69 payments — averaging $128.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Medtronic$1K
  • Axonics, Inc.$787
  • AbbVie$198
  • BD$171
  • Conmed Corporation$140
  • plus $559 from 17 others
$87,794in research payments, 2019–2025

Across 55 payments — averaging $1596.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biontech SE$88K

What the payments were for

  • Speaking & faculty fees$2,20025%
  • Travel & lodging$2,69230%
  • Food & beverage$2,00123%
  • Education$2,00022%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,893 in reported general payments places this provider in the 65th percentile of 176 colon & rectal surgery providers in California.

See all colon & rectal surgery providers in California

Medicare billing

Part B allowed, 2024
$166,570
Medicare patients
218
Services billed
630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates24$1,556
Neomycin Sulfate25$133
Metronidazole27$31
Ondansetron Hcl18$26
Tramadol Hcl14$18

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Walnut Creek

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →